MTCM
SNTI icon

Mint Tower Capital Management’s Senti Biosciences Holdings SNTI Stock Holding History

Mint Tower Capital Management’s Portfolio SNTI Stock Details SNTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-10,000
Closed -$987K – 440
2022
Q1 		$987K Hold
10,000
– – 0.09% 168
2021
Q4 		$986K Hold
10,000
– – 0.13% 167
2021
Q3 		$994K Hold
10,000
– – 0.13% 150
2021
Q2 		$994K Buy
+10,000
New +$998K 0.07% 190

Other funds holding SNTI

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
CCM
CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return
IC
Intel Corp Santa Clara, California $621M AUM 34.06% 1-Year Est. Return
FMN
Financial Management Network Mission Viejo, California $695M AUM 13.16% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
KC
Kingfisher Capital Charlotte, North Carolina $437M AUM 41.72% 1-Year Est. Return

Mint Tower Capital Management's SNTI Position: Q2 2022 in Review

Mint Tower Capital Management sold out of Senti Biosciences Holdings (SNTI) in Q2 2022, closing a stake of 10,000 shares — an estimated $987K sold.

Mint Tower Capital Management first reported a position in SNTI in Q2 2021 and held it in 4 quarters. The position peaked at $994K in Q3 2021. 22 funds tracked by Wall St. Rank hold SNTI as of Q2 2022.

  • Mint Tower Capital Management reported no remaining Senti Biosciences Holdings position as of Q2 2022 after selling out during the quarter.
  • Mint Tower Capital Management sold 10,000 Senti Biosciences Holdings shares in Q2 2022, an estimated $987K.
  • Mint Tower Capital Management first reported a position in Senti Biosciences Holdings in Q2 2021 and held it in 4 quarters.
  • Mint Tower Capital Management's Senti Biosciences Holdings position peaked at $994K in Q3 2021.
  • 22 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q2 2022.

Based on Mint Tower Capital Management's 13F filing for Q2 2022, filed 5 Aug 2022.